News | July 22, 2013

CenTrak's Real-Time Location System Aids Patient Experience at Florida Cancer Specialists

July 22, 2013 — Vizzia Technologies announced that its clinical workflow optimization solution was recently installed at Florida Cancer Specialists and Research Institute's (FCS) Tampa Cancer Center location. The newly constructed 35,990 square foot flagship facility offers a "one-stop" approach to patient care that includes medical oncology, advanced radiation oncology technology and radiological services for identifying and diagnosing tumors. The Vizzia solution, which leverages CenTrak's Clinical-Grade RTLS, is designed to transform the outpatient experience and help in optimizing patient flow processes. Shortening patient wait times and ensuring patient safety and satisfaction, as well as increasing the cancer center's patient treatment capacity are among the benefits of the new solution.

"Cancer treatment can be a daunting challenge for many of our patients. We are proud to have installed the latest technologies to enhance our patients' experiences at our center. Vizzia's advanced workflow solution allows us the visibility and data we need to accelerate the overall treatment process, so our patients can more quickly return to their normal routines," said Todd Schonherz, Florida Cancer Specialists' chief operating officer.

Vizzia integrated its Web-based information portal with the CenTrak Clinical-Grade Locating infrastructure. Their Vizzion Suite software automatically updates the location of patients and staff from CenTrak's RTLS and incorporates important workflow rules and alerts to ensure that patients move through the treatment process as efficiently as possible. The Clinical-Grade RTLS platform uses battery-operated Gen2IR and Virtual Wall devices to deliver unmatched room-, bed-, and bay-level accuracy. The advanced technology delivers rapid location update speeds and offers small, full-featured tags with extremely long battery life.

For more information: www.vizziatech.com.

Related Content

The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%

Varian's Ethos artificial intelligence radiotherapy device.

News | Radiation Oncology | September 28, 2021
September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848
Esaote, an Italian company leader in the biomedical equipment sector – ultrasound, MRI and software for the medical sector – launched E-shop: the new online store to reach medical professionals more quickly and effectively.
News | Radiology Business | September 27, 2021
September 27, 2021 — Esaote, an Italian company leader in the biomedical equipment sector –...
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.

Getty Images

News | Prostate Cancer | September 24, 2021
September 24, 2021 — Scientists have identified two subtypes of metastatic...
Owkin, a startup that deploys artificial intelligence (AI) and Federated Learning technologies to augment medical research and enable scientific discoveries, presented findings in Hepatocellular Carcinoma (HCC) with Cleveland Clinic at the 2021 European Society of Medical Oncology (ESMO) conference.

Illustration courtesy of Cleveland Clinic

News | Artificial Intelligence | September 24, 2021
September 24, 2021 — Owkin, a startup that deploys...
The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s Fixed), By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End User, By Region, Competition Forecast & Opportunities, 2026" report

Image courtesy of Varian

News | Radiation Therapy | September 24, 2021
September 24, 2021 — The ...
The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center, Medical University of South Carolina Hollings Cancer Center and City of Hope Comprehensive Cancer Center secured a highly competitive Specialized Program of Research Excellence (SPORE) grant that aims to address lung cancer racial disparities through precision medicine, targeted smoking cessation programs and community outreach.

VCU Massey Cancer Center director and SPORE principal investigator Dr. Robert Winn explains how this grant will help combat racial inequities in lung cancer. Image courtesy of VCU Massey Cancer Center

News | Lung Imaging | September 23, 2021
September 23, 2021 — The National Cancer Institute announced tha
This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021
September 22, 2021 — The RACE AI study conducted by Gustave...
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
Non-oncology doctors’ knowledge of oncology is frequently not up to date, with risks in the communication with patients  

Getty Images

News | Radiation Oncology | September 20, 2021
September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, me